img

Global COVID-19 Molecular Diagnostics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global COVID-19 Molecular Diagnostics Market Insights, Forecast to 2034

COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
Market Analysis and InsightsGlobal COVID-19 Molecular Diagnostics Market
The global COVID-19 Molecular Diagnostics market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for COVID-19 Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for COVID-19 Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for COVID-19 Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key companies of COVID-19 Molecular Diagnostics include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Thermo Fisher and Bio-rad, etc. in 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for COVID-19 Molecular Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2023, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of COVID-19 Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for COVID-19 Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COVID-19 Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global COVID-19 Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for COVID-19 Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Thermo Fisher and Bio-rad, etc.



By Company


Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Thermo Fisher
Bio-rad
Agilent
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
QIAGEN
Bioer
Biosynex
Esco
Analytik Jena
Techne
Da An Gene
BGI
Shanghai ZJ Bio-Tech
Segment by Type
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection

Segment by Application


Hospitals
Scientific Research
Biodiagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of COVID-19 Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of COVID-19 Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COVID-19 Molecular Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 High-throughput Sequencing
1.2.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.4 Immunological Detection
1.3 Market by Application
1.3.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Molecular Diagnostics Market Perspective (2018-2033)
2.2 Global COVID-19 Molecular Diagnostics Growth Trends by Region
2.2.1 COVID-19 Molecular Diagnostics Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 COVID-19 Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 COVID-19 Molecular Diagnostics Market Dynamics
2.3.1 COVID-19 Molecular Diagnostics Industry Trends
2.3.2 COVID-19 Molecular Diagnostics Market Drivers
2.3.3 COVID-19 Molecular Diagnostics Market Challenges
2.3.4 COVID-19 Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue COVID-19 Molecular Diagnostics by Players
3.1.1 Global COVID-19 Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of COVID-19 Molecular Diagnostics, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global COVID-19 Molecular Diagnostics Market Concentration Ratio
3.4.1 Global COVID-19 Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Molecular Diagnostics Revenue in 2023
3.5 Global Key Players of COVID-19 Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of COVID-19 Molecular Diagnostics, Product and Application
3.7 Global Key Players of COVID-19 Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Molecular Diagnostics Breakdown Data by Type
4.1 Global COVID-19 Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2024-2033)
5 COVID-19 Molecular Diagnostics Breakdown Data by Application
5.1 Global COVID-19 Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 Molecular Diagnostics Market Size (2018-2033)
6.2 North America COVID-19 Molecular Diagnostics Market Size by Type
6.2.1 North America COVID-19 Molecular Diagnostics Market Size by Type (2018-2023)
6.2.2 North America COVID-19 Molecular Diagnostics Market Size by Type (2024-2033)
6.2.3 North America COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
6.3 North America COVID-19 Molecular Diagnostics Market Size by Application
6.3.1 North America COVID-19 Molecular Diagnostics Market Size by Application (2018-2023)
6.3.2 North America COVID-19 Molecular Diagnostics Market Size by Application (2024-2033)
6.3.3 North America COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
6.4 North America COVID-19 Molecular Diagnostics Market Size by Country
6.4.1 North America COVID-19 Molecular Diagnostics Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
6.4.3 North America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe COVID-19 Molecular Diagnostics Market Size (2018-2033)
7.2 Europe COVID-19 Molecular Diagnostics Market Size by Type
7.2.1 Europe COVID-19 Molecular Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe COVID-19 Molecular Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
7.3 Europe COVID-19 Molecular Diagnostics Market Size by Application
7.3.1 Europe COVID-19 Molecular Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe COVID-19 Molecular Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
7.4 Europe COVID-19 Molecular Diagnostics Market Size by Country
7.4.1 Europe COVID-19 Molecular Diagnostics Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China COVID-19 Molecular Diagnostics Market Size (2018-2033)
8.2 China COVID-19 Molecular Diagnostics Market Size by Type
8.2.1 China COVID-19 Molecular Diagnostics Market Size by Type (2018-2023)
8.2.2 China COVID-19 Molecular Diagnostics Market Size by Type (2024-2033)
8.2.3 China COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
8.3 China COVID-19 Molecular Diagnostics Market Size by Application
8.3.1 China COVID-19 Molecular Diagnostics Market Size by Application (2018-2023)
8.3.2 China COVID-19 Molecular Diagnostics Market Size by Application (2024-2033)
8.3.3 China COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia COVID-19 Molecular Diagnostics Market Size (2018-2033)
9.2 Asia COVID-19 Molecular Diagnostics Market Size by Type
9.2.1 Asia COVID-19 Molecular Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia COVID-19 Molecular Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
9.3 Asia COVID-19 Molecular Diagnostics Market Size by Application
9.3.1 Asia COVID-19 Molecular Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia COVID-19 Molecular Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
9.4 Asia COVID-19 Molecular Diagnostics Market Size by Region
9.4.1 Asia COVID-19 Molecular Diagnostics Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia COVID-19 Molecular Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia COVID-19 Molecular Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
11.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.1.5 Cellex Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Molecular Diagnostics Introduction
11.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.3.5 Roche Recent Developments
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
11.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.4.5 BioMedomics Recent Developments
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Molecular Diagnostics Introduction
11.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.5.5 BD Recent Developments
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
11.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.6.5 Henry Schein Recent Developments
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.7.5 Safecare Bio-Tech Recent Developments
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Details
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
11.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.8.5 Thermo Fisher Recent Developments
11.9 Bio-rad
11.9.1 Bio-rad Company Details
11.9.2 Bio-rad Business Overview
11.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
11.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.9.5 Bio-rad Recent Developments
11.10 Agilent
11.10.1 Agilent Company Details
11.10.2 Agilent Business Overview
11.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
11.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.10.5 Agilent Recent Developments
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Developments
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Details
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.12.5 Zhejiang Orient Gene Biotech Recent Developments
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Details
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.13.5 Innovita Biological Technology Recent Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.14.5 Guangzhou Wondfo Biotech Recent Developments
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Details
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.15.5 Guangdong Hecin-Scientific Recent Developments
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Details
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
11.17 ADVAITE
11.17.1 ADVAITE Company Details
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
11.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.17.5 ADVAITE Recent Developments
11.18 Mayo Clinic Laboratories
11.18.1 Mayo Clinic Laboratories Company Details
11.18.2 Mayo Clinic Laboratories Business Overview
11.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
11.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.18.5 Mayo Clinic Laboratories Recent Developments
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Details
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
11.19.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.19.5 Chembio Diagnostics Recent Developments
11.20 Mount Sinai Laboratory
11.20.1 Mount Sinai Laboratory Company Details
11.20.2 Mount Sinai Laboratory Business Overview
11.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
11.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.20.5 Mount Sinai Laboratory Recent Developments
11.21 QIAGEN
11.21.1 QIAGEN Company Details
11.21.2 QIAGEN Business Overview
11.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
11.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.21.5 QIAGEN Recent Developments
11.22 Bioer
11.22.1 Bioer Company Details
11.22.2 Bioer Business Overview
11.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
11.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.22.5 Bioer Recent Developments
11.23 Biosynex
11.23.1 Biosynex Company Details
11.23.2 Biosynex Business Overview
11.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
11.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.23.5 Biosynex Recent Developments
11.24 Esco
11.24.1 Esco Company Details
11.24.2 Esco Business Overview
11.24.3 Esco COVID-19 Molecular Diagnostics Introduction
11.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.24.5 Esco Recent Developments
11.25 Analytik Jena
11.25.1 Analytik Jena Company Details
11.25.2 Analytik Jena Business Overview
11.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
11.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.25.5 Analytik Jena Recent Developments
11.26 Techne
11.26.1 Techne Company Details
11.26.2 Techne Business Overview
11.26.3 Techne COVID-19 Molecular Diagnostics Introduction
11.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.26.5 Techne Recent Developments
11.27 Da An Gene
11.27.1 Da An Gene Company Details
11.27.2 Da An Gene Business Overview
11.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
11.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.27.5 Da An Gene Recent Developments
11.28 BGI
11.28.1 BGI Company Details
11.28.2 BGI Business Overview
11.28.3 BGI COVID-19 Molecular Diagnostics Introduction
11.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.28.5 BGI Recent Developments
11.29 Shanghai ZJ Bio-Tech
11.29.1 Shanghai ZJ Bio-Tech Company Details
11.29.2 Shanghai ZJ Bio-Tech Business Overview
11.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
11.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.29.5 Shanghai ZJ Bio-Tech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of High-throughput Sequencing
Table 3. Key Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 4. Key Players of Immunological Detection
Table 5. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global COVID-19 Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global COVID-19 Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global COVID-19 Molecular Diagnostics Market Share by Region (2018-2023)
Table 9. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global COVID-19 Molecular Diagnostics Market Share by Region (2024-2033)
Table 11. COVID-19 Molecular Diagnostics Market Trends
Table 12. COVID-19 Molecular Diagnostics Market Drivers
Table 13. COVID-19 Molecular Diagnostics Market Challenges
Table 14. COVID-19 Molecular Diagnostics Market Restraints
Table 15. Global COVID-19 Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global COVID-19 Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 17. Global Top COVID-19 Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Table 18. Global COVID-19 Molecular Diagnostics Industry Ranking 2021 VS 2023 VS 2023
Table 19. Global 5 Largest Players Market Share by COVID-19 Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of COVID-19 Molecular Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of COVID-19 Molecular Diagnostics, Product and Application
Table 22. Global Key Players of COVID-19 Molecular Diagnostics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global COVID-19 Molecular Diagnostics Revenue Share by Application (2018-2023)
Table 30. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global COVID-19 Molecular Diagnostics Revenue Share by Application (2024-2033)
Table 32. North America COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America COVID-19 Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America COVID-19 Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America COVID-19 Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. North America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe COVID-19 Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe COVID-19 Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe COVID-19 Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Europe COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. China COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China COVID-19 Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 48. China COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China COVID-19 Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia COVID-19 Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia COVID-19 Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia COVID-19 Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 55. Asia COVID-19 Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia COVID-19 Molecular Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 62. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 64. Cellex Company Details
Table 65. Cellex Business Overview
Table 66. Cellex COVID-19 Molecular Diagnostics Product
Table 67. Cellex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 68. Cellex Recent Developments
Table 69. Abbott Company Details
Table 70. Abbott Business Overview
Table 71. Abbott COVID-19 Molecular Diagnostics Product
Table 72. Abbott Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Abbott Recent Developments
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche COVID-19 Molecular Diagnostics Product
Table 77. Roche Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Roche Recent Developments
Table 79. BioMedomics Company Details
Table 80. BioMedomics Business Overview
Table 81. BioMedomics COVID-19 Molecular Diagnostics Product
Table 82. BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 83. BioMedomics Recent Developments
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD COVID-19 Molecular Diagnostics Product
Table 87. BD Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 88. BD Recent Developments
Table 89. Henry Schein Company Details
Table 90. Henry Schein Business Overview
Table 91. Henry Schein COVID-19 Molecular Diagnostics Product
Table 92. Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Henry Schein Recent Developments
Table 94. Safecare Bio-Tech Company Details
Table 95. Safecare Bio-Tech Business Overview
Table 96. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product
Table 97. Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Safecare Bio-Tech Recent Developments
Table 99. Thermo Fisher Company Details
Table 100. Thermo Fisher Business Overview
Table 101. Thermo Fisher COVID-19 Molecular Diagnostics Product
Table 102. Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Thermo Fisher Recent Developments
Table 104. Bio-rad Company Details
Table 105. Bio-rad Business Overview
Table 106. Bio-rad COVID-19 Molecular Diagnostics Product
Table 107. Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Bio-rad Recent Developments
Table 109. Agilent Company Details
Table 110. Agilent Business Overview
Table 111. Agilent COVID-19 Molecular Diagnostics Product
Table 112. Agilent Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Agilent Recent Developments
Table 114. Ortho Clinical Diagnostics Company Details
Table 115. Ortho Clinical Diagnostics Business Overview
Table 116. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product
Table 117. Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Ortho Clinical Diagnostics Recent Developments
Table 119. Zhejiang Orient Gene Biotech Company Details
Table 120. Zhejiang Orient Gene Biotech Business Overview
Table 121. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product
Table 122. Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Zhejiang Orient Gene Biotech Recent Developments
Table 124. Innovita Biological Technology Company Details
Table 125. Innovita Biological Technology Business Overview
Table 126. Innovita Biological Technology COVID-19 Molecular Diagnostics Product
Table 127. Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Innovita Biological Technology Recent Developments
Table 129. Guangzhou Wondfo Biotech Company Details
Table 130. Guangzhou Wondfo Biotech Business Overview
Table 131. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product
Table 132. Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Guangzhou Wondfo Biotech Recent Developments
Table 134. Guangdong Hecin-Scientific Company Details
Table 135. Guangdong Hecin-Scientific Business Overview
Table 136. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product
Table 137. Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Guangdong Hecin-Scientific Recent Developments
Table 139. Dynamiker Biotechnology (Tianjin) Company Details
Table 140. Dynamiker Biotechnology (Tianjin) Business Overview
Table 141. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product
Table 142. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 144. ADVAITE Company Details
Table 145. ADVAITE Business Overview
Table 146. ADVAITE COVID-19 Molecular Diagnostics Product
Table 147. ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 148. ADVAITE Recent Developments
Table 149. Mayo Clinic Laboratories Company Details
Table 150. Mayo Clinic Laboratories Business Overview
Table 151. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product
Table 152. Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 153. Mayo Clinic Laboratories Recent Developments
Table 154. Chembio Diagnostics Company Details
Table 155. Chembio Diagnostics Business Overview
Table 156. Chembio Diagnostics COVID-19 Molecular Diagnostics Product
Table 157. Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 158. Chembio Diagnostics Recent Developments
Table 159. Mount Sinai Laboratory Company Details
Table 160. Mount Sinai Laboratory Business Overview
Table 161. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product
Table 162. Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 163. Mount Sinai Laboratory Recent Developments
Table 164. QIAGEN Company Details
Table 165. QIAGEN Business Overview
Table 166. QIAGEN COVID-19 Molecular Diagnostics Product
Table 167. QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 168. QIAGEN Recent Developments
Table 169. Bioer Company Details
Table 170. Bioer Business Overview
Table 171. Bioer COVID-19 Molecular Diagnostics Product
Table 172. Bioer Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 173. Bioer Recent Developments
Table 174. Biosynex Company Details
Table 175. Biosynex Business Overview
Table 176. Biosynex COVID-19 Molecular Diagnostics Product
Table 177. Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 178. Biosynex Recent Developments
Table 179. Esco Company Details
Table 180. Esco Business Overview
Table 181. Esco COVID-19 Molecular Diagnostics Product
Table 182. Esco Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 183. Esco Recent Developments
Table 184. Analytik Jena Company Details
Table 185. Analytik Jena Business Overview
Table 186. Analytik Jena COVID-19 Molecular Diagnostics Product
Table 187. Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 188. Analytik Jena Recent Developments
Table 189. Techne Company Details
Table 190. Techne Business Overview
Table 191. Techne COVID-19 Molecular Diagnostics Product
Table 192. Techne Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 193. Techne Recent Developments
Table 194. Da An Gene Company Details
Table 195. Da An Gene Business Overview
Table 196. Da An Gene COVID-19 Molecular Diagnostics Product
Table 197. Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 198. Da An Gene Recent Developments
Table 199. BGI Company Details
Table 200. BGI Business Overview
Table 201. BGI COVID-19 Molecular Diagnostics Product
Table 202. BGI Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 203. BGI Recent Developments
Table 204. Shanghai ZJ Bio-Tech Company Details
Table 205. Shanghai ZJ Bio-Tech Business Overview
Table 206. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product
Table 207. Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 208. Shanghai ZJ Bio-Tech Recent Developments
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global COVID-19 Molecular Diagnostics Market Share by Type: 2023 VS 2033
Figure 3. High-throughput Sequencing Features
Figure 4. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Features
Figure 5. Immunological Detection Features
Figure 6. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 7. Global COVID-19 Molecular Diagnostics Market Share by Application: 2023 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Biodiagnostics Case Studies
Figure 11. COVID-19 Molecular Diagnostics Report Years Considered
Figure 12. Global COVID-19 Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global COVID-19 Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 14. Global COVID-19 Molecular Diagnostics Market Share by Region: 2023 VS 2033
Figure 15. Global COVID-19 Molecular Diagnostics Market Share by Players in 2023
Figure 16. Global Top COVID-19 Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
Figure 18. North America COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
Figure 20. North America COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
Figure 21. North America COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 22. United States COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe COVID-19 Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
Figure 26. Europe COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
Figure 27. Europe COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 28. Germany COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China COVID-19 Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
Figure 36. China COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
Figure 37. Asia COVID-19 Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
Figure 39. Asia COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
Figure 40. Asia COVID-19 Molecular Diagnostics Market Share by Region (2018-2033)
Figure 41. Japan COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 51. Brazil COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Cellex Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 60. BioMedomics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 61. BD Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 62. Henry Schein Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 63. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 64. Thermo Fisher Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 65. Bio-rad Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 66. Agilent Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 67. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 68. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 69. Innovita Biological Technology Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 70. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 71. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 72. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 73. ADVAITE Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 74. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 75. Chembio Diagnostics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 76. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 77. QIAGEN Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 78. Bioer Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 79. Biosynex Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 80. Esco Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 81. Analytik Jena Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 82. Techne Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 83. Da An Gene Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 84. BGI Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 85. Shanghai ZJ Bio-Tech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries